Search

Background18F-Flutemetamol (18F-FMM) PET/CT imaging has been widely applied to the diagnosis of mild cognitive impairment and Alzheimer's disease.PurposeThis study aims to explore the distributions of 18F-FMM in different brain regions of mild cognitive impairment (MCI) and Alzheimer's disease (AD) patients and the factors that may affect the combination of 18F-FMM, evaluating the use of 18F-FMM PET/CT imaging in the diagnosis of MCI and AD patients.MethodsFrom July 2020 to April 2021, 24 subjects with MCI (12 males, 12 females, aged of (70.54±9.27) years old), 25 subjects with AD (11 males, 14 females, aged (70.56±7.30) years old) and 9 subjects as normal controls (NC, 2 males, 7 females, aged (57.67±9.00) years old) were recruited from Shanghai. The 18F-FMM PET/CT brain imaging of all subjects were qualitatively and semi-quantitatively analyzed by visual evaluation and standardized uptake value ratio (SUVR), respectively. Student's t-test, one-way analysis of variance and rank sum test were used for the comparison of quantitative variables. Pearson's chi-squared test and Fisher's exact test were used for the comparison of qualitative variables. The diagnostic efficiency was obtained by ROC curve. Multiple linear regression analysis was used to analyze the factors that might affect the combination of 18F-FMM.ResultsThe positive rate of visual assessment was significantly different in NC, MCI and AD groups (χ2=26.85, p < 0.001), and significant differences existed statistically in SUVR of all brain regions among the three groups (H value: 11.54~19.34, F value: 7.43, 11.48, all p < 0.01). The mean values of SUVR in the whole brain of the three groups were statistically different (Z value: -3.87, -2.79, -2.45, all p < 0.016 7). Compared with MCI group, the positive rate in occipital lobe, temporal lobe, parietal lobe and posterior cingulate gyrus was statistically significant (χ2=7.53~10.89, all p < 0.01). With respect to NC, SUVR of all brain regions was lower than that in AD, while SUVR of temporal lobe, frontal lobe and precuneu were lower than that in MCI. Meanwhile, SUVR of occipital lobe, temporal lobe, frontal lobe and parietal lobe in MCI were lower than that in AD. Receiver operating characteristic (ROC) curves showed that the SUVR value of temporal lobe and the mean value of SUVR in the whole brain had the ability to distinguish NC, MCI and AD in sequence. Multiple linear regression analysis showed that cognitive level was significantly negatively correlated with 18F-FMM SUVR in different brain regions.Conclusion18F-FMM PET/CT brain imaging could reflect the cognitive level of middle-aged and elderly people intuitively and has clear diagnostic value for MCI and AD.

BackgroundSubjective cognitive decline (SCD) and mild cognitive impairment (MCI) are a transitional state between normal aging and mild dementia, and most of them have potential Alzheimer's Disease (AD) pathology. Studying the pathophysiological characteristics of SCD and MCI is helpful to the early diagnosis of AD.PurposeThis study aims to investigate the brain perfusion differences among SCD, MCI and AD, and to evaluate the application value of brain perfusion SPECT/CT imaging combined with NeuroGamTM software in these diseases.MethodsFrom July 2020 to April 2021, 15 patients with SCD, 29 patients with MCI and 36 patients with AD were collected from several general hospitals in Shanghai. All subjects underwent neuropsychological test and 99mTc-ECD brain perfusion SPECT/CT imaging. The perfusion levels of Brodmann areas (BA) in the three groups were semi-quantitatively analyzed by NeuroGamTM, and compared with normal database. Student's t-test, one-way analysis of variance and rank sum test were used for the comparison of quantitative variables. Pearson's chi-squared test was used for the comparison of qualitative variables.ResultsThere is no significant difference in BA 4~11, 17~25, 28, 31~32, 36~40 and 44~47 between SCD group and MCI group. The mean perfusion values of BA 8-right(R), 20-left(L), 21R, 23L, 23R, 24L, 31L, 38L, 38R and 45R in SCD group are significantly higher than those in AD group (p

Based on the analysis of the existing methods for estimating the surface flattening error, they can be roughly classified into two types of estimation methods: the relative area error analysis method and the relative length error analysis method. The advantages and disadvantages of these methods are summarized in the paper. Combining the general surface flattening methods and sheet metal stamping forming process, a more reasonable, scientific and comprehensive evaluation system for the accuracy of surface flattening is proposed. In line with the unfolding characteristics of the grid surface, the relative average area error of triangles is used instead of the traditional area error estimation method. The accumulated length error is replaced by the relative length error of each triangle in the estimation method, and the value of the change in the orientation (direction, position) relationship between the triangles is increased to assess the deformation error of the surface flattening method. The mass attributes of the patch are introduced. The minimum displacement energy method is used to supplement the evaluation of surface flattening accuracy. Finally, a comprehensive evaluation system is established and proposed, which takes into account the accuracy of local and global surface flattening.

Radium-223 dichloride (223Ra) (Sofigo), a calcium-mimetic agent that specifically targets bone lesions, was approved in 2020 by China Food and Drug Administration (CFDA) to treat castration‑resistant prostate cancer and bone metastases (CRPC) with symptomatic bone metastases and no known visceral metastatic diseases. It is the fisrt α particles targeted radiopharmaceutical therapeutic drugs in the world to be applied to CRPC with bone metastase (mCRPC) patients. In recent years, the application of nuclear medicine technology to evaluate the efficacy of 223Ra in the treatment of mCRPC patients abroad has been very common, but only few hospitals in China have entered the stage of clinical application. In order to provide clear recommendations for clinical applications of radionuclide imaging in evaluating the efficacy of 223Ra in the treatment of mCRPC, a survey of recent progress is carried out in this study, and public available clinical data of single photon emission computed tomography/computed tomography (SPECT/CT), and positron emission tomography/computed tomography (PET/CT) using radiolabeled chemical agents worldwide in the evaluation of 223Ra treatment for patients with CRPC and bone metastase,are presented and commented.

Objective: The aim was to study whether the computed tomography (CT) density and β-amyloid (Aβ) level of intraorbital optic nerve could assist in diagnosing mild cognitive impairment (MCI) and Alzheimer's disease (AD). Methods: A total of sixty subjects were recruited in our study, including nine normal control (NC) subjects (i.e., 4 men and 5 women), twenty four MCI subjects (i.e., 11 men and 13 women), and twenty seven AD subjects (i.e., 14 men and 13 women). All subjects conducted 18F-flutemetamol amyloid positron emission tomography (PET)/CT imaging. Blinded to the clinical information of the subjects, two physicians independently measured and calculated the standardized uptake value ratio (SUVR) of the bilateral occipital cortex, SUVR of the bilateral intraorbital optic nerve, and CT density of the bilateral intraorbital optic nerve by using GE AW 4.5 Workstation. Results: Between AD and NC groups, the differences of the bilateral intraorbital optic nerve SUVR were statistically significant; between AD and MCI groups, the differences of the left intraorbital optic nerve SUVR were statistically significant. Between any two of the three groups, the differences in the bilateral intraorbital optic nerve density were statistically significant. The bilateral occipital SUVR was positively correlated with the bilateral intraorbital optic nerve SUVR and negatively correlated with the bilateral intraorbital optic nerve density. Bilateral intraorbital optic nerve SUVR was negatively correlated with the bilateral intraorbital optic nerve density. The area under the receiver operating characteristic (ROC) curve of multiple logistic regression was 0.9167 (for MCI vs. NC) and 0.8951 (for AD vs. MCI). The Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) scores were positively associated with the intraorbital optic nerve density and were negatively associated with the intraorbital optic nerve SUVR. The regression equation of MoCA was y = 16.37-0.9734 × x 1 + 0.5642 × x 2-3.127 × x 3 + 0.0275 × x 4; the R 2 was 0.848. The regression equation of MMSE was y = 19.57-1.633 × x 1 + 0.4397 × x 2-1.713 × x 3 + 0.0424 × x 4; the R 2 was 0.827. Conclusion: The CT density and Aβ deposition of the intraorbital optic nerve were associated with Aβ deposition of the occipital cortex and the severity of cognitive impairment. The intraorbital optic nerve CT density and intraorbital optic nerve Aβ deposition could assist in diagnosing MCI and AD. [ABSTRACT FROM AUTHOR]

Objectives: To assess the efficacy and safety of 99mTc-TRODAT-1 SPECT in diagnosing Parkinson's disease (PD).Methods: 99mTc-TRODAT-1 SPECT imaging was performed in 34 healthy controls and 96 PD patients 2.5 h later after injection. The striatal image was evaluated visually and semi-quantitively. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT were analyzed according to Hoehn and Yahr scale (HYS). Based on HYS, the PD patients were divided into mild (HYS 1-2) and moderate (HYS 3-5) groups. The uptake ratios of striatum (ST) and cerebellum (CB) in contralateral, ipsilateral and bilateral striatum in different groups were calculated and analyzed. The safety was assessed.Results: The sensitivity and specificity of 99mTc-TRODAT-1 SPECT to discriminate PD patients from healthy subjects were 98.96% and 94.12% and it has perfect agreement with HYS (κ = 0.94, p < 0.001). The sensitivity to diagnose mild and moderate PD was 43.42% and 95% separately. The uptake ratio in PD patients was significantly lower than that in healthy controls (1.37 ± 0.13 vs 1.68 ± 0.18, p < 0.001). And the uptake ratio in contralateral side was markedly reduced in unilateral PD patients as compared with the ipsilateral side (1.50 ± 0.20 vs 1.46 ± 0.21, p < 0.001). The striatal uptakes in affected striatum and bilateral striatum were reduced with increasing disease severity between healthy control versus mild stage versus moderate stage in the affected striatum and bilateral striatum in PD patients. No serious adverse events or death was observed after injecting 99mTc-TRODAT-1.Conclusion: We demonstrated that 99mTc-TRODAT-1 was a safety radiotracer which can be used in clinic to diagnose PD using SPECT. [ABSTRACT FROM AUTHOR]

Objective: The aim was to study whether the computed tomography (CT) density and β-amyloid (Aβ) level of intraorbital optic nerve could assist in diagnosing mild cognitive impairment (MCI) and Alzheimer's disease (AD)., Methods: A total of sixty subjects were recruited in our study, including nine normal control (NC) subjects (i.e., 4 men and 5 women), twenty four MCI subjects (i.e., 11 men and 13 women), and twenty seven AD subjects (i.e., 14 men and 13 women). All subjects conducted 18 F-flutemetamol amyloid positron emission tomography (PET)/CT imaging. Blinded to the clinical information of the subjects, two physicians independently measured and calculated the standardized uptake value ratio (SUVR) of the bilateral occipital cortex, SUVR of the bilateral intraorbital optic nerve, and CT density of the bilateral intraorbital optic nerve by using GE AW 4.5 Workstation., Results: Between AD and NC groups, the differences of the bilateral intraorbital optic nerve SUVR were statistically significant; between AD and MCI groups, the differences of the left intraorbital optic nerve SUVR were statistically significant. Between any two of the three groups, the differences in the bilateral intraorbital optic nerve density were statistically significant. The bilateral occipital SUVR was positively correlated with the bilateral intraorbital optic nerve SUVR and negatively correlated with the bilateral intraorbital optic nerve density. Bilateral intraorbital optic nerve SUVR was negatively correlated with the bilateral intraorbital optic nerve density. The area under the receiver operating characteristic (ROC) curve of multiple logistic regression was 0.9167 (for MCI vs. NC) and 0.8951 (for AD vs. MCI). The Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) scores were positively associated with the intraorbital optic nerve density and were negatively associated with the intraorbital optic nerve SUVR. The regression equation of MoCA was y = 16.37-0.9734 × x 1 + 0.5642 × x 2 -3.127 × x 3 + 0.0275 × x 4 ; the R 2 was 0.848. The regression equation of MMSE was y = 19.57-1.633 × x 1 + 0.4397 × x 2 -1.713 × x 3 + 0.0424 × x 4 ; the R 2 was 0.827., Conclusion: The CT density and Aβ deposition of the intraorbital optic nerve were associated with Aβ deposition of the occipital cortex and the severity of cognitive impairment. The intraorbital optic nerve CT density and intraorbital optic nerve Aβ deposition could assist in diagnosing MCI and AD., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. JZ declared a shared parent affiliation with XL at the time of review., (Copyright © 2022 Wu, Lei, Ou, Shi, Xu, Shi, Ding, Zhao, Wang, Cai, Liu, Lou and Liu.)